logo
Select company
Select metric
$ 12.97MNet Cash Flow - Financing
VS
Market
31
Sector
38
Industry
47
History
47
$ 0.19Close
$ 0.14 - $ 3.59 52-Week Range
Ticker Information

Ticker

GNPX

Company Name

GENPREX INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

GENPREX INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GNPX - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 12.97M
3/31/2025$ 11.25M
12/31/2024$ 12.01M
9/30/2024$ 8.03M
6/30/2024$ 13.33M
3/31/2024$ 13.31M
12/31/2023$ 10.59M
9/30/2023$ 10.6M
6/30/2023$ 4.09M
3/31/2023$ 4.09M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • GENPREX INC's latest trailing twelve months (TTM) CF - Financing stands at $ 30.36M.
  • Over the past 5 years, GENPREX INC's average CF - Financing has been $ 15.83M.
  • The median CF - Financing for GENPREX INC during this period was $ 11.63M
  • GENPREX INC reached its highest CF - Financing over the past 5 years at $ 41.59M.
  • The lowest CF - Financing recorded by GENPREX INC in the same timeframe $ 1.75K

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

GNPX - Net Cash Flow - Financing, Last 5 years

$ 1.75K

Minimum

Sep 30, 2022

$ 41.59M

Maximum

Dec 31, 2020

$ 15.83M

Average

$ 11.63M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.84M with a standard deviation of $ 119.27M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -367.1M
max$ 366M
average$ -6.84M
median$ 305K
std$ 119.27M